Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)

Charles L. Loprinzi, Rui Qin, Shaker R. Dakhil, Louis Fehrenbacher, Kathleen A. Flynn, Pamela Atherton, Drew Seisler, Rubina Qamar, Grant C. Lewis, Axel Grothey

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)'. Together they form a unique fingerprint.

Medicine & Life Sciences